(Q46981410)

27 December 2017

title

Conformationally restricted cyclic analogues of substance P: insight into the receptor binding process (English)

1 reference

27 December 2017

0 references

Darman PS

1

1 reference

27 December 2017

Landis GC

2

1 reference

27 December 2017

Smits JR

3

1 reference

27 December 2017

Hirning LD

4

1 reference

27 December 2017

Gulya K

5

1 reference

27 December 2017

Yamamura HI

6

1 reference

27 December 2017

Burks TF

7

1 reference

27 December 2017

Hruby VJ

8

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 March 1985

1 reference

27 December 2017

Biochemical and Biophysical Research Communications

published in

1 reference

27 December 2017

volume

127

1 reference

27 December 2017

issue

2

1 reference

27 December 2017

page(s)

656-662

1 reference

27 December 2017

Substance P: Localization in the Central Nervous System and in Some Primary Sensory Neurons

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

Substance P and opiate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

7 January 2021

Synthesis of substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

Studies on Peptides. XXXIV. Conventional Synthesis of the Undecapeptide Amide corresponding to the Entire Amino Acid Sequence of Bovine Substance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

The possible existence of multiple receptors for substance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

Synthesis of peptides by the solid-phase method. V. Substance P and analogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

A substance P antagonist inhibits a slow reflex response in the spinal cord of the newborn rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

Substance P antagonists active in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

Conformational studies on substance P C-terminal pentapeptide pGlu-Phe-Phe-Gly-Leu-Met NH2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

Conformational restrictions of biologically active peptides via amino acid side chain groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

Solid-phase synthesis of (2-isoleucine, 4-leucine) oxytocin and (2-phenylalanine, 4-leucine) oxytocin and some their pharmacological properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

Synthesis of leucine enkephalin derivatives: Structure-function studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

High-affinity 3H-substance P binding to longitudinal muscle membranes of the guinea pig small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

Binding of flexible ligands to macromolecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2885%2980211-4

10.1016/S0006-291X(85)80211-4

7 January 2021

Identifiers

DOI

1 reference

27 December 2017

PubMed ID

2579658

1 reference

27 December 2017